Bancorp 34, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Bancorp 34, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $1.69M | Mar 6, 2025 |
| FY2024 | Dec 31, 2023 | ($3.40M) | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | $1.33M | Mar 8, 2024 |
| FY2019 | Dec 31, 2019 | $710.2K | Feb 18, 2020 |
| FY2019 | Dec 31, 2018 | $1.07M | Feb 18, 2020 |
| FY2018 | Dec 31, 2017 | $360.6K | Feb 19, 2019 |
| FY2017 | Dec 31, 2016 | $5.30M | Mar 14, 2018 |
| FY2016 | Dec 31, 2015 | $320.6K | Mar 23, 2017 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $2.97M | Mar 6, 2025 |
| FY2024 | Dec 31, 2023 | $910.0K | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | $9.76M | Mar 8, 2024 |
| FY2019 | Dec 31, 2019 | $31.99M | Feb 18, 2020 |
| FY2019 | Dec 31, 2018 | ($7.24M) | Feb 18, 2020 |
| FY2018 | Dec 31, 2017 | $15.43M | Feb 19, 2019 |
| FY2017 | Dec 31, 2016 | $6.92M | Mar 14, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $500.0K | Mar 6, 2025 |
| FY2024 | Dec 31, 2023 | $226.0K | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | $684.0K | Mar 8, 2024 |
| FY2019 | Dec 31, 2019 | $20.0K | Feb 18, 2020 |
| FY2019 | Dec 31, 2018 | $197.7K | Feb 18, 2020 |
| FY2018 | Dec 31, 2017 | $685.0K | Feb 19, 2019 |
| FY2017 | Dec 31, 2016 | $919.1K | Mar 14, 2018 |
| FY2016 | Dec 31, 2015 | $417.8K | Mar 23, 2017 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $918.10M | Mar 6, 2025 |
| FY2024 | Dec 31, 2023 | $581.27M | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | $574.34M | Mar 8, 2024 |
| FY2019 | Dec 31, 2019 | $393.74M | Feb 18, 2020 |
| FY2019 | Dec 31, 2018 | $383.28M | Feb 18, 2020 |
| FY2018 | Dec 31, 2017 | $336.22M | Feb 19, 2019 |
| FY2017 | Dec 31, 2016 | $328.87M | Mar 14, 2018 |
| FY2016 | Dec 31, 2015 | $270.98M | Mar 23, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $831.58M | Mar 6, 2025 |
| FY2024 | Dec 31, 2023 | $520.54M | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | $525.10M | Mar 8, 2024 |
| FY2019 | Dec 31, 2019 | $348.66M | Feb 18, 2020 |
| FY2019 | Dec 31, 2018 | $336.86M | Feb 18, 2020 |
| FY2018 | Dec 31, 2017 | $285.25M | Feb 19, 2019 |
| FY2017 | Dec 31, 2016 | $278.09M | Mar 14, 2018 |
| FY2016 | Dec 31, 2015 | $241.34M | Mar 23, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $86.52M | Mar 6, 2025 |
| FY2024 | Dec 31, 2023 | $60.72M | Mar 6, 2025 |
| FY2024 | Dec 31, 2022 | $48.58M | Mar 6, 2025 |
| FY2023 | Dec 31, 2021 | $40.67M | Mar 8, 2024 |
| FY2019 | Dec 31, 2019 | $45.08M | Feb 18, 2020 |
| FY2019 | Dec 31, 2018 | $46.42M | Feb 18, 2020 |
| FY2019 | Dec 31, 2017 | $50.97M | Feb 18, 2020 |
| FY2018 | Dec 31, 2016 | $50.78M | Feb 19, 2019 |
| FY2017 | Dec 31, 2015 | $29.64M | Mar 14, 2018 |
| FY2016 | Dec 31, 2014 | $29.34M | Mar 23, 2017 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $25.99M | Mar 6, 2025 |
| FY2024 | Dec 31, 2023 | $24.30M | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | $29.01M | Mar 8, 2024 |
| FY2019 | Dec 31, 2019 | $23.16M | Feb 18, 2020 |
| FY2019 | Dec 31, 2018 | $22.93M | Feb 18, 2020 |
| FY2018 | Dec 31, 2017 | $26.06M | Feb 19, 2019 |
| FY2017 | Dec 31, 2016 | $25.70M | Mar 14, 2018 |
| FY2016 | Dec 31, 2015 | $20.40M | Mar 23, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $29.49M | Feb 18, 2020 |
| FY2019 | Dec 31, 2018 | $11.77M | Feb 18, 2020 |
| FY2019 | Dec 31, 2017 | $9.87M | Feb 18, 2020 |
| FY2018 | Dec 31, 2016 | $16.41M | Feb 19, 2019 |
| FY2017 | Dec 31, 2015 | $19.82M | Mar 14, 2018 |
| FY2016 | Dec 31, 2014 | $14.82M | Mar 23, 2017 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $28.50M | Mar 6, 2025 |
| FY2023 | Dec 31, 2023 | $54.00M | Mar 8, 2024 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 0 | Mar 6, 2025 |
| FY2024 | Dec 31, 2023 | 0 | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 8, 2024 |
| FY2019 | Dec 31, 2019 | 0 | Feb 18, 2020 |
| FY2019 | Dec 31, 2018 | 0 | Feb 18, 2020 |
| FY2018 | Dec 31, 2017 | 0 | Feb 19, 2019 |
| FY2017 | Dec 31, 2016 | 1 | Mar 14, 2018 |
| FY2016 | Dec 31, 2015 | 0 | Mar 23, 2017 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 0 | Mar 6, 2025 |
| FY2024 | Dec 31, 2023 | 0 | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 8, 2024 |
| FY2019 | Dec 31, 2019 | 0 | Feb 18, 2020 |
| FY2019 | Dec 31, 2018 | 0 | Feb 18, 2020 |
| FY2018 | Dec 31, 2017 | 0 | Feb 19, 2019 |
| FY2017 | Dec 31, 2016 | 1 | Mar 14, 2018 |
| FY2016 | Dec 31, 2015 | 0 | Mar 23, 2017 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | 3.21M | Feb 18, 2020 |
| FY2019 | Dec 31, 2018 | 3.37M | Feb 18, 2020 |
| FY2018 | Dec 31, 2017 | 3.49M | Feb 19, 2019 |
| FY2017 | Dec 31, 2016 | 3.44M | Mar 14, 2018 |
| FY2019 | Oct 11, 2016 | 3.44M | Feb 18, 2020 |
| FY2016 | Dec 31, 2015 | 3.44M | Mar 23, 2017 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2023 | $656.0K | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | $700.0K | Mar 8, 2024 |